NanoString Technologies' nCounter miRGE Assay is designed to enable researchers to investigate expression levels of both micro RNAs (miRNAs) and the messenger RNAs (mRNAs) they potentially regulate in a single reaction, without the need for amplification.
The miRGE Assay provides the capacity to perform multiplexed profiling of 5-30
miRNAs and 100-200 mRNAs simultaneously, with specificity and sensitivity
comparable to qPCR. Like all nCounter assays, the kit is compatible with
multiple sample types, including FFPE samples. The assay is available for
human, mouse and rat samples.
The nCounter Analysis System is a fully automated digital detection and
counting system with a simple workflow. The assays contain all of the
reagents and consumables required to conduct an experiment. Minimal sample
input requirements and compatibility with a variety of sample types, extends
the utility of the platform. In addition to miRNA assays, NanoString
provides assays for copy number variation and gene expression analysis. The
nCounter Analysis System is currently available for research use only.
This Product is made by:
NanoString Technologies is a privately held provider of life science tools for
translational research and developer of molecular diagnostics. The company’s
nCounter® Analysis System is the first and only technology platform to
deliver highly multiplexed, direct profiling of individual molecules in a
single reaction without amplification. The nCounter Analysis System offers a
cost-effective way to easily profile hundreds of gene transcripts, copy
number variations, or miRNAs simultaneously with high sensitivity and
precision. The company’s technology enables a wide variety of basic
research and translational medicine applications, including biomarker
discovery and validation. NanoString is also developing the technology for
use in molecular diagnostics.